So far the number of confirmed COVID-19 cases in the United States nears the 2.74M (+52609) mark.
A kind of specific buzz has been created by the US gov. by delivering few surprising words. The United States has stated the nation is going to grab approximately the entire stock of the remdesivir at the global level. This medication has been specified and proven to be very effective against the coronavirus. It is one of the two drugs currently being used for treating coronavirus patients.
By releasing a press statement, the United States Department of Health and Human Services told that it will be buying up virtually the whole produced stock of remdesivir from its manufacturer Gilead till the month of September.
The agency added more words in its statement as "it secured approx more than 5 Lakh remdesivir courses for hospitals of United through September.
It clearly indicates that all of the production of Gilead is projected with the US for the month of July, and also 90% of its production in August as well as September.
Alex Azar, Secretary of Department of Health and Human Services stated as, “President Donald Trump has struck a very crucial deal in order to ensure that all Americans have access to the first authorised therapeutic for COVID-19 pandemic."
This statement comes a couple of days after Gilead Sciences declared its pricing plan for the current popular antiviral drug. The drugmaker announced the treatment would cost $2,340 (approximately Rs 1.77 lakh) per patient for those nations who are wealthier, and added that approx all of its supply would be sold to the United States for the upcoming 3 months, Reuters reported.
The remdesivir was Initially developed in order to treat Ebola. It becomes the first drug which comes up as very effective to help patients recover from the illness rapidly during the clinical trials. In the month of May 2020, the remdesivir holds the emergency authorisation from the US FDA in order to treat Covid-19 patients.
In India, too, the remdesivir is recommended for use in the moderate stage of coronavirus.
This antiviral drug as an emergency use of authorization can be considered for moderate staged patients who required oxygen support.
Apart from this remdesivir injection shouldn't be recommended for those patients who are with severe renal impairment and high level of liver enzymes. Females who are pregnant and those patients below the age of 12 years must avoid this drug, the Health Ministry has stated.
Reference link:-
コメント